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The Shiga-toxin-producing, non-sorbitol-fermenting, and β-glucuronidase-negative *Escherichia coli* (STEC) O157:H7 strain is thought to have evolved from an O55:H7-like progenitor ([@B1], [@B2]). The O157:H7 serotype is now the most common enterohemorrhagic *E. coli* (EHEC) found in North America. Although it causes disease in humans, *E. coli* O157:H7 asymptomatically colonizes cattle, which is[ ](#T1){ref-type="table"}the major reservoir for this organism ([@B3], [@B4]). *E. coli* O157:H7 is distinguished from other serotypes by its genetically homogenous population structure and it exhibits a high degree of proteome conservation and a syntenic chromosomal backbone disrupted by interspersed phages ([@B5], [@B6]). The rapid emergence of *E. coli* O157:H7 from being an unknown strain in 1982 to being the dominant hemorrhagic serotype in the United States and the cause of widespread outbreaks of human food-borne illness highlights a need to critically evaluate the extent to which the genomic plasticity of this important enteric pathogen contributes to human disease severity and bovine niche adaptation. An estimated 15 to 20% of infected patients present with indications severe enough to require hospitalization. Symptoms may progress to hemolytic uremic syndrome, renal failure, hemorrhagic colitis, and central nervous system failure, with potentially lethal outcomes. Yet, little is known about the genomic diversity that exists among extant *E. coli* O157:H7 populations or how various genotypes of this pathogen relate to the development and severity of the clinical manifestations in infected patients.

###### 

Genome features of the 26 EHEC strains

  Strain     Genome size (Mbp)   Contigs   Accession no.
  ---------- ------------------- --------- ------------------------------
  EC1734     5.42                54        [AKMO00000000](AKMO00000000)
  EC1738     5.47                62        [AKMN00000000](AKMN00000000)
  EC4013     5.35                463       [AKMH00000000](AKMH00000000)
  EC4203     5.39                552       [AKMB00000000](AKMB00000000)
  EC4402     5.44                785       [AKMI00000000](AKMI00000000)
  EC4421     5.31                437       [AKMF00000000](AKMF00000000)
  EC4422     5.31                393       [AKMG00000000](AKMG00000000)
  EC4436     5.41                456       [AKMK00000000](AKMK00000000)
  EC4439     5.4                 534       [AKMJ00000000](AKMJ00000000)
  EC4448     5.49                566       [AKMM00000000](AKMM00000000)
  FDA505     5.35                540       [AKKW00000000](AKKW00000000)
  FDA517     5.52                533       [AKKX00000000](AKKX00000000)
  FRIK1985   5.54                730       [AKKZ00000000](AKKZ00000000)
  FRIK1990   5.51                629       [AKLA00000000](AKLA00000000)
  FRIK1996   5.43                580       [AKKY00000000](AKKY00000000)
  PA3        5.36                508       [AKLC00000000](AKLC00000000)
  PA5        5.35                554       [AKLD00000000](AKLD00000000)
  PA9        5.42                427       [AKLE00000000](AKLE00000000)
  TW07945    5.36                404       [AKLU00000000](AKLU00000000)
  TW09098    5.48                486       [AKLX00000000](AKLX00000000)
  TW09109    5.57                66        [AKLY00000000](AKLY00000000)
  TW09195    5.46                1288      [AKLZ00000000](AKLZ00000000)
  TW10119    5.55                56        [AKMA00000000](AKMA00000000)
  TW10246    5.45                47        [AKLV00000000](AKLV00000000)
  TW11039    5.6                 71        [AKLW00000000](AKLW00000000)
  TW14301    5.29                485       [AKME00000000](AKME00000000)

Strains for sequencing were selected to represent phylogenetically diverse isolates within the O157:H7 lineage based on multiple typing assays ([@B1], [@B5]--[@B7]). Genomic DNA was subjected to next-generation Illumina HiSeq 2000 (300-bp insert size, 100-bp paired-end reads) or Illumina and 454 FLX/XLR (3-kb insert size) hybrid sequencing followed by assembly as described previously ([@B8]). Hybrid and Illumina assemblies were generated using the Celera and Velvet assemblers, respectively ([@B9], [@B10]), and all chromosomes and plasmids were manually annotated using the Manatee system (<http://manatee.sourceforge.net/>). Genome architectures and gene inventory were compared using Mauve and BLAST Score Ratio analysis ([@B11], [@B12]). Strains were further characterized using phylogenomic assays of the genomic backbone and mobilome to investigate plasticity in architectures, prophage profiles, and single nucleotide polymorphisms ([@B5], [@B6]). Access to these high-quality genome sequences and their comparative analyses with relatives or other serotypes will facilitate additional comprehensive bioinformatics and phylogenetic analyses, thus expanding our understanding of the pathogenomic evolution of this major public health problem caused by these pathogens. These data should also prove useful for the development of a refined phylogenomic framework for forensic, diagnostic, and epidemiological studies in order to better prepare for future outbreaks and for better risk assessment in response to novel and emerging *E. coli* O157:H7 biotypes.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

The genome sequences are deposited in GenBank under the accession no. listed in [Table 1](#T1){ref-type="table"}. Cultures are available from the Biodefense and Emerging Infections Research Resources Repository (<http://www.beiresources.org/>).

**Citation** Eppinger M, Daugherty S, Agrawal S, Galens K, Sengamalay N, Sadzewicz L, Tallon L, Cebula TA, Mammel MK, Feng P, Soderlund R, Tarr PI, DebRoy C, Dudley EG, Fraser CM, Ravel J. 2013. Whole-genome draft sequences of 26 enterohemorrhagic *Escherichia coli* O157:H7 strains. Genome Announc. 1(2):e00134-12. doi:10.1128/genomeA.00134-12.

This project was funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract no. HHSN272200900007C.
